Proliferating cell nuclear antigen and argyrophilic nucleolar organizer regions in patients with thymic disease

Oncology Reports

Volumn 4, Issue 6, 1997, Pages 1201-1205

  Oyama, Tsunehiro ^a,d   Osaki, Toshihiro ^a   Mitsudomi, Tetsuya ^b   Mizoue, Tetsuya ^a   Ohgami, Akira ^a   Nakanishi, Ryoichi ^a   Sugio, Kenji ^c   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Ag NOR; PCNA; Thymic carcinoma; Thymic hyperplasia; Thymoma

Indexed keywords

CYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LABELING INDEX; MALE; PRIORITY JOURNAL; SURVIVAL RATE; THYMOMA; THYMUS CANCER; THYMUS DISEASE; THYMUS HYPERPLASIA;

EID: 0030884764     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.6.1201     Document Type: Article

References (51)

1. Egan M and Crocker J: Evaluation of nucleolar organizer regions in pulmonary pathology. Thorax 45: 225-232, 1990.
2. Goodpasture C and Bloom SE: Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromosoma 53: 37-50, 1975.
3. Howell WM, Denton TE and Diamond JR: Differential staining of the satellite regions of acrocentric chromosomes. Experientia 31: 260-262, 1975.
4. Egan MJ and Crocker J: Nucleolar organizer regions in pathology. Br J Cancer 65: 1-7, 1992.
5. Öfner D, Totsch M, Sandbichler P, Hallbrucker CHR, Margreiter R, Mikuz G and Schmid KW: Silver stained nucleolar organizer region proteins (Ag-NORs) as a predictor of prognosis in colon cancer. J Pathol 162: 43-49, 1990.
6. Rüschoff J, Bittinger A, Neumannn K and Schmitz-Moormann P: Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol Res Pract 186: 85-91, 1990.
7. Morita M, Kuwano H, Matsuda H, Moriguchi S and Sugimachi K: Prognostic significance of argyrophilic organizer regions in esophageal carcinoma. Cancer Res 51: 5339-5341, 1991.
8. Kaneko S, Ishida T, Sugio K, Yokoyama H and Sugimachi K: Nucleoler organizer regions as a prognostic indicator for stage I non-small cell lung cancer. Cancer Res 51: 4008-4011, 1991.
9. Oyama T, Mitudomi T, Yoshida Y, Mizoue T, Hamada T and Shirakusa T: Nucleolar organizer region are independently associated with a shortened survival of patients with non-small cell lung cancer. Surg Oncol 2: 341-347, 1993.
10. Tan EM: Autoantibodies to nuclear antigens (ANA). Their immunobiology and medicine. Adv Immunol 33: 167-240, 1982.
11. Miyachi K, Fritzler MJ and Tan EM: Autoantibodies to a nuclear antigen in proliferating cells. J Immunol 121: 2228-2234, 1978.
12. Prelich G, Tan C-K, Kostura M, Mathews MB, So AG, Downey KM and Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein. Nature 326: 517-520, 1987.
13. Brove R, Frank R, Blundell PA and MacDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326: 515-517, 1987.
14. Kunkel TA, Sabatino RD and Bambara RA: Exonucleolytic proofreading by self thymus DNA polymerase-δ. Proc Natl Acad Sci USA 84: 4865-4869, 1987.
15. Galand P and Degraef C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22: 383-392, 1989.
16. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohnåò R, Dover R, Waseem NH and Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
17. Garcia RI, Coltrera MD and Grown AM: Analysis proliferative grade using PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 134: 733-739, 1989.
18. Carey FA, Fabbroni G and Lamb D: Expression of proliferating cell nuclear antigen in lung cancer: a systematic study and correlation with DNA ploidy. Histopathology 20: 499-503, 1992.
19. Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin M, Bigini D, Vignati S, Pingitore R and Angeletti CA: The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer 70: 1520-1527, 1992.
20. Quinn CM and Wright NA: The clinical assessment of proliferation and growth in human tumors; evaluation of methods and applications as prognostic variables. J Pathol 160: 93-102, 1990.
21. Theunissen PHMH, Leers MPG and Bollen ECM: Proliferating cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small cell lung carcinoma. Histopathology 20: 251-255, 1992.
22. Oyama T, Mitudomi T, Mizoue T, Ohgami A, Osaki R, Nakanishi R and Yasumoto K: Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer. Surg Oncol 4: 83-89, 1995.
23. Fontanini G, Pingitore R, Bigini D, Vignati S, Pepe S, Ruggiero A and Macchiarini P: Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Am J Pathol 141: 1285-1289, 1992.
24. Pescarmona E, Rendina EA, Venuta F, D'Arcangelo E, Pagani M, Ricci C, Ruco LP and Baroni CD: Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 50: 534-538, 1990.
25. Masaoka A, Monden Y, Nakahara K and Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485-2492, 1981.
26. Lewis JE, Wick MR, Scheithauer BW, Bematz PE and Taylor WF: Thymoma: a clinical review. Cancer 60: 2727-2743, 1987.
27. Marino M and Müller-Hermelink HK: Thymoma and thymic carcinoma. Virchows Arch (A) 407: 119-149, 1985.
28. Rosai J and Levine GD: Tumors of the Thymus. Armed Forces Institute of Pathology, Washington DC, 1976.
29. Levine GD and Rosai J: Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9: 495-515, 1978.
30. Crocker J, Boldy JAR and Egan MJ: How should we count AgNORs? Proposals for a standardized approach. J Pathol 158: 185-188, 1989.
31. Kaplan E and Meier P: Non-parametric estimation from incomplete observation. J Amer Statist Assn 53: 457-481, 1958.
32. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
33. Risio M and Rossini FP: Cell proliferation in colorectal adenomas containing invasive carcinoma. Anticancer Res 13: 43-47, 1993.
34. Raymond WA and Leong AS-Y: Nucleolar organizer regions relate to growth fractions in human breast carcinoma. Hum Pathol 20: 741-746, 1989.
35. Sakr WA, Sarkar FH, Sreepathi P, Drozdowicz S and Crissman JD: Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF. Prostate 22: 147-54, 1993.
36. Soomro I, Patel N and Whimster WF: Distribution and estimation of nucleolar organizer regions in various human lung tumors. Pathol Res Pract 187: 68-72, 1991.
37. Miyazaki S, Sasano H, Suzuki T, Sawai T, Nishihira T and Mori S: Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining. Modern Pathol 5: 396-401, 1992.
38. Rahilly MA, Edwards CW, Crocker J and Murray P: Epithelial cell type, clinical behaviour and AgNOR counts in thymic epithelial tumors. Anal Cell Pathol 3: 203-213, 1991.
39. Tateyama H, Mizuno T, Tada T, Eimoto T, Hashimoto T and Masaoka A: Thymic epithelial tumours: evaluation of malignant grade by quantification of proliferating cell nuclear antigen and nucleolar organizer regions. Virchows Arch (A) 422: 265-269, 1993.
40. Skopelitou A, Korkolopoulou P, Papanicolaou A, Christodoulou P, Thomas-Tsagli E and Pavlakis K: Comparative assessment of proliferating cell nuclear antigen immunostaining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters. Eur Urol 22: 235-240, 1992.
41. Yu CC, Fletcher CD, Newman PL, Goodlad JR, Burton JC and Levison DA: A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumors. J Pathol 166: 147-152, 1992.
42. Benner SE, Hong WK, Lippman SM, Lee JS and Hittelman WM: Intermediate biomarker in upper aerodigestive tract and lung chemoprevention trials. J Cell Biochem 16G (Suppl.): 33-38, 1992.
43. Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Dalla Palma P and Doglioni C: Tumor suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol 166: 343-350, 1992.
44. VanDierendonck JH, Wysman JH, Keyzer R, van de Velde CJH and Cornelisse CJ: Cell-cycle-related staining patterns of antiproliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdURd labelling and Ki-67 staining. Am J Pathol 138: 1165-1172, 1991.
45. Tsuji T, Sasaki K, Kimura Y, Yamada K, Mori M and Shinozaki F: Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers. Int J Oral Maxillofac Surg 21: 369-372, 1992.
46. Korkolopoulou P, Patsouris E, Pangalis G, Tsenga A, Elemenoglou J, Thomas-Tsagli E, Spandidos D and Kittas C: A comparative assessment of proliferating cell nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases. Hum Pathol 24: 371-377, 1993.
47. Evans AT, Blessing K, Orrell JM and Grant A: Mitotic indices, anti-PCNA immunostaining, and AgNORs in thick cutaneous melanomas displaying paradoxical behaviour. J Pathol 168: 15-22, 1992.
48. Pich A, Chiusa L, Pisani P, Krengli M, Pia F and Navone R: Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. J Cancer Res Clin Oncol 119: 106-110, 1992.
49. Pich A, Chiarle R, Chiusa L and Palestro G: Argyrophilic nucleolar organizer region counts predict survival in thymoma. Cancer 74: 1568-1574, 1994.
50. Minna JD: The molecular biology of lung cancer pathogenesis. Chest 103 (Suppl.): 445S-456S, 1993.
51. Tateyama H, Eimoto T, Tada T, Mizuno T, Inagaki H, Hata A, Sasaki M and Masaoka A: p53 protein expression and p53 gene mutation in thymic epithelial tumors. Am J Clin Pathol 104: 375-381, 1995.